SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

Needham Maintains Buy on Flexion Therapeutics, Lowers Price Target to $20

Needham maintains Flexion Therapeutics (NASDAQ:FLXN) with a Buy and lowers the price target from $30 to $20.

Benzinga · 05/08/2020 14:49

Needham maintains Flexion Therapeutics (NASDAQ:FLXN) with a Buy and lowers the price target from $30 to $20.